search for




 

Case Report
A Case of Recurrent Steroid-dependent Kikuchi–Fujimoto Disease Successfully Treated with Hydroxychloroquine
Clin Pediatr Hematol Oncol 2017;24:144-7.
Published online October 31, 2017
© 2017 Korean Society of Pediatric Hematology-Oncology and Korean Society for Pediatric Neuro-Oncology

Kyung Mi Jang, M.D. and Jae Min Lee, M.D.

Department of Pediatrics, Yeungnam University College of Medicine, Daegu, Korea
Correspondence to: Jae Min Lee
Department of Pediatrics, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea
Tel: +82-53-620-3536 Fax: +82-53-629-2252 E-mail: mopic@yu.ac.kr
Received August 24, 2017; Revised September 11, 2017; Accepted October 9, 2017.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Kikuchi–Fujimoto disease (KFD) is known as a self-limiting disease. The most common symptoms include fever, cervical lymphadenopathy, and pain, but nonspecific symptoms such as joint pain, nausea, chills, diaphoresis, and diarrhea may also be present. Its clinical course is generally benign, and symptoms including fever disappear within several months without special treatment. Thus, there is no specific recommended treatment for patients with KFD. However, some patients suffer from prolonged fever or systemic symptoms such as splenomegaly, skin rash, arthralgia, and aseptic meningitis. Many studies have reported the effectiveness of corticosteroids in patients with prolonged fever and systemic symptoms. Our patient also responded favorably to steroids; however, the disease relapsed while tapering. Recently, some studies reported the effectiveness of hydroxychloroquine (HC) in patients with KFD. Herein, we report successful treatment with HC in an adolescent patient with recurrent KFD dependent on steroids without any symptoms of autoimmune disease.
Keywords: Kikuchi–Fujimoto disease, Histiocytic necrotizing lymphadenitis, Hydroxy-chloroquine, Children, Lymphadenopathy
References
  1. Hutchinson CB, Wang E. Kikuchi-Fujimoto disease. Arch Pathol Lab Med 2010;134:289-93.
    Pubmed
  2. Tsang WY, Chan JK. Fine-needle aspiration cytologic diagnosis of Kikuchi's lymphadenitis. A report of 27 cases. Am J Clin Pathol 1994;102:454-8.
    Pubmed CrossRef
  3. Bosch X, Guilabert A. Kikuchi-Fujimoto disease. Orphanet J Rare Dis 2006;1:18.
    Pubmed KoreaMed CrossRef
  4. Lee KY, Yeon YH, Lee BC. Kikuchi-Fujimoto disease with prolonged fever in children. Pediatrics 2004;114:e752-6.
    Pubmed CrossRef
  5. Rakesh P, Alex RG, Varghese GM, et al. Kikuchi-fujimoto disease: clinical and laboratory characteristics and outcome. J Glob Infect Dis 2014;6:147-50.
    Pubmed KoreaMed CrossRef
  6. Deaver D, Horna P, Cualing H, Sokol L. Pathogenesis, diagnosis, and management of Kikuchi-Fujimoto disease. Cancer Control 2014;21:313-21.
    Pubmed CrossRef
  7. Kato K, Ohshima K, Anzai K, Suzumiya J, Kikuchi M. Elevated serum-soluble Fas ligand in histiocytic necrotizing lymphadenitis. Int J Hematol 2001;73:84-6.
    Pubmed CrossRef
  8. Kubota M, Tsukamoto R, Kurokawa K, Imai T, Furusho K. Elevated serum interferon gamma and interleukin-6 in patients with necrotizing lymphadenitis (Kikuchi's disease). Br J Haematol 1996;95:613-5.
    Pubmed CrossRef
  9. Facchetti F, Vermi W, Mason D, Colonna M. The plasmacytoid monocyte/interferon producing cells. Virchows Arch 2003; 443:703-17.
    Pubmed CrossRef
  10. Song JY, Lee J, Park DW, et al. Clinical outcome and predictive factors of recurrence among patients with Kikuchi's disease. Int J Infect Dis 2009;13:322-6.
    Pubmed CrossRef
  11. Hyun M, So IT, Kim HA, Jung H, Ryu SY. Recurrent Kikuchi's disease treated by hydroxychloroquine. Infect Chemother 2016;48:127-31.
    Pubmed KoreaMed CrossRef
  12. Uslu E, Gurbuz S, Erden A, et al. Disseminated intravascular coagulopathy caused by Kikuchi-Fujimoto disease resulting in death: first case report in Turkey. Int Med Case Rep J 2014;7: 19-22.
    Pubmed KoreaMed
  13. Yoshioka K, Miyashita T, Nakamura T, Inoue T, Yamagami K. Treatment of histiocytic necrotizing lymphadenitis (Kikuchi's disease) with prolonged fever by a single course of methylprednisolone pulse therapy without maintenance therapy: experience with 13 cases. Intern Med 2010;49:2267-70.
    Pubmed CrossRef
  14. Gilman AL, Schultz KR, Goldman FD, et al. Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study. Biol Blood Marrow Transplant 2012;18:84-91.
    Pubmed KoreaMed CrossRef
  15. Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol 2014;132:1453-60.
    Pubmed CrossRef


April 2018, 25 (1)
Full Text PDF
Citation
Send to a friend
Twitter
Facebook

Cited By Articles
  • CrossRef (0)

Author ORCID Information
  • Jae Min Lee